(MENAFN- GlobeNewsWire - Nasdaq) HTS opportunities center on AI-enabled automation, personalized medicine and Asia-Pacific expansion, with trends in miniaturized, multiplexed, label-free assays and cloud data tools.Dublin, Sept. 14, 2026 (GLOBE NEWSWIRE) -- "High Throughput Screening (HTS) Market Report 2026" has been added to ResearchAndMarkets.com's offering.
High-Throughput Screening Market to Reach $38.34 Billion by 2030 as AI and Laboratory Automation Advance Drug Discovery
The global high-throughput screening (HTS) market is experiencing strong growth, supported by increasing pharmaceutical and biotechnology research, greater demand for faster drug discovery, and continued advances in laboratory automation. The market is projected to grow from $25.26 billion in 2025 to $27.47 billion in 2026, representing a compound annual growth rate (CAGR) of 8.7%.
Historic market expansion has been driven by rising demand for rapid drug discovery, improvements in assay technologies, increased pharmaceutical research and development spending, and broader adoption of robotics in laboratories. The continued expansion of contract research organizations has also strengthened demand for high-throughput screening instruments, software, consumables, reagents, and related services.
The high-throughput screening market is forecast to reach $38.34 billion by 2030, expanding at a CAGR of 8.7% from 2026. Key growth factors include the integration of artificial intelligence and machine learning into screening workflows, the expansion of personalized medicine, increased investment in biotechnology startups, and growing life sciences activity across emerging Asia-Pacific markets. The development of multiplexed and label-free assay technologies is also expected to create new opportunities for market participants.
Prominent high-throughput screening market trends include greater automation integration, the miniaturization of screening platforms, advanced detection technologies, multiplexed assay development, and cloud-based data management. These capabilities enable pharmaceutical companies, biotechnology businesses, academic institutions, and contract research organizations to process larger sample volumes while improving operational efficiency, accuracy, and data accessibility.
The rising prevalence of chronic diseases is expected to remain a major driver of HTS market growth. High-throughput screening supports the rapid evaluation of extensive chemical compound libraries to identify potential drug candidates targeting disease-related pathways and mechanisms. This capability is increasingly important as healthcare systems seek new treatments for long-term conditions. In January 2023, the National Library of Medicine reported that the number of people aged 50 and older in the United States with at least one chronic condition is projected to reach 142.66 million by 2050.
Product innovation is further strengthening the market outlook. In February 2023, PerkinElmer introduced the EnVision Nexus multimode plate reader for demanding high-throughput screening applications. The system incorporates dual detectors, optimized reagents, assay flexibility, and automation options designed to accelerate drug discovery. Plate-stacking configurations for 20 or 50 plates, along with full automation and integration capabilities, support continuous laboratory operations and the efficient screening of large sample volumes.
Strategic acquisitions are also reshaping the competitive landscape. In December 2023, PerkinElmer acquired Covaris for an undisclosed amount. The transaction was intended to expand PerkinElmer's life sciences portfolio and strengthen its position in the growing diagnostics market while supporting the development of advanced high-throughput screening solutions.
North America was the largest region in the high-throughput screening market in 2025, reflecting its established pharmaceutical industry, extensive biotechnology research infrastructure, and significant investment in drug discovery technologies. Asia-Pacific is expected to be the fastest-growing region during the forecast period. Regions covered by the high-throughput screening market include Asia-Pacific, Southeast Asia, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. Countries covered include Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, the United Kingdom, the United States, Canada, Italy, and Spain.
Markets Covered:
1) By Products And Services: Consumables And Reagents; Instruments; Software And Services
2) By Technology: Ultra-High-Throughput Screening; Cell-Based Assays; Lab-On-A-Chip; Label-Free Technology
3) By Application: Target Identification And Validation; Primary And Secondary Screening; Toxicology Assessment; Other Applications
4) By End User: Pharmaceuticals And Biotechnology Industry; Academics And Research Institute; Contract Research Organization; Other End Users
Subsegments:
1) By Consumables And Reagents: Assay Plates; Reagents And Assay Kits; Sample Preparation Kits; Detection Reagents
2) By Instruments: Automated Liquid Handlers; Plate Readers; Robotics And Automation Systems; Microfluidic Devices
3) By Software And Services: Data Analysis Software; HTS Management Software; Consulting Services; Maintenance And Support Services
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Key Attributes:
CONTACT:
CONTACT: ResearchAndMarkets.com
Laura Wood,Senior Press Manager...
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Comments
No comment